Jiangxi Jiangzhong Pharmaceutical Enters Distribution Business
This article was originally published in PharmAsia News
Executive Summary
Jiangxi Jiangzhong Pharmaceutical, China's leading OTC drug company, will acquire stakes in Jointown Group's subsidiary Jiangxi Jointown Pharmaceutical with 11.18 million yuan (1.62 million). At the same time, it will pump in 18.8 million yuan ($2.73 million) to increase its equity in Jiangxi Jointown, securing 51 percent of the firm in total. Analysts say the move will expand the marketshare of Jiangzhong Pharmaceutical's brand and products to gain a dominant position in Jiangxi. Jointown can bring complementary products into the region and develop its end-user market through the collaboration. Observers note the trend of pharmaceutical companies entering drug distribution to control the end-user retail market will have significant impact on the domestic industry. (Click here for more - Chinese Language)